Have a personal or library account? Click to login
Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii Cover

Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii

Open Access
|Dec 2019

References

  1. 1. Akil, I., Yilmaz, O., Kurutepe, S., Deqerli, K., Kavukcu, S. (2006). Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatric nephrology, 21(6), 807-810. http://dx.doi.org/10.1007/s00467-006-0088-410.1007/s00467-006-0088-416703374
  2. 2. Anvari, M., Khayati, G., Rostami, S. (2013). Optimisation of medium composition for probiotic biomass production using response surface methodology. Journal of Dairy Research, 81(01), 59–64. http://dx.doi.org/10.1017/s002202991300073310.1017/s0022029913000733
  3. 3. Buts, J. P., Dekeyser, N., Stilmant, C., Delem, E., Smets, F., Sokal, E. (2006). Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coil endotoxin by dephosphorylation. Pediatric Research, 60(1), 24-29. http://dx.doi.org/10.1203/01.pdr.0000220322.31940.2910.1203/01.pdr.0000220322.31940.2916690953
  4. 4. Cheng, Fangfang., Chen, He., Lei, Ni., Zhang, Meng., Wan, Hongchang., Shu, Guowei. (2019). Effect of prebiotics, inorganic salts and amino acids for cell envelope proteinase production from Lactobacillus plantarum LP69. Acta scientiarum polonorum. Technologia alimentaria, 18(3). http://dx.doi.org/10.17306/J.AFS.065610.17306/J.AFS.065631569909
  5. 5. Corona-Hernandez, R. I., Álvarez-Parrilla, E., Lizardi-Mendoza, J., Islas-Rubio, A. R., de la Rosa, L. A., Wall-Medrano, A. (2013). Structural Stability and Viability of Microencapsulated Probiotic Bacteria: A Review. Comprehensive Reviews in Food Science and Food Safety, 12(6), 614–628. http://dx.doi.org/10.1111/1541-4337.1203010.1111/1541-4337.1203033412721
  6. 6. Czerucka, D., Piche, T., Rampal, P. (2010). Review article: yeast as probiotics -- Saccharomyces boulardii. Alimentary Pharmacology & Therapeutics, 26(6), 767-778. http://dx.doi.org/10.1111/j.1365-2036.2007.03442.x10.1111/j.1365-2036.2007.03442.x17767461
  7. 7. Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S. G., Stateva, L. (2007). Genotypic and physiological characterization of Saccharomyces boulardii, the proboscis strain of Saccharomyces cerevisiae. Applied and Environmental Microbiology, 73(8), 2458-2467. http://dx.doi.org/10.1128/AEM.02201-0610.1128/AEM.02201-06185559417293506
  8. 8. Elmer, G. W., Mcfarland, L. V., Surawicz, C. M., Danko, L., Greenberg, R. N. (2000). Behaviour of saccharomyces boulardii in recurrent clostridium difficile disease patients. Alimentary Pharmacology & Therapeutics, 13(12), 1663-1668. http://dx.doi.org/10.1046/j.1365-2036.1999.00666.x10.1046/j.1365-2036.1999.00666.x10594402
  9. 9. Fietto, J. L., Araújo, R. S., Valadão, F. N., Fietto, L. G., Brandão, R. L., Neves, M. J., Gomes, F. C., Nicoli, J. R., Castro, I. M. (2004). Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Canadian Journal of Microbiology, 50(8), 615- 621. http://dx.doi.org/10.1139/w04-05010.1139/w04-05015467787
  10. 10. George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., Das, G. (2018). Benefaction of probiotics for human health: A review. Journal of Food and Drug Analysis, 26(3), 927–939. http://dx.doi.org/10.1016/j.jfda.2018.01.00210.1016/j.jfda.2018.01.00229976412
  11. 11. Ghasem, B., Hosnie, G., Bahare, Z., Najmeh, Z., Farzin, R., Ardakani, E.M., Azizi, M., Khalaj, V. (2018). Oral administration of recombinant Saccharomyces boulardii expressing ovalbumin-cpe fusion protein induces antibody response in mice. Frontiers in Microbiology, 9, 723-. http://dx.doi.org/10.3389/fmicb.2018.0072310.3389/fmicb.2018.00723
  12. 12. Kailasapathy, K. (2015). Encapsulation and controlled release techniques for administration and delivery of bioactive components in the health food sector. Nutraceutical and Functional Food Processing Technology, John Wiley & Sons, Ltd.10.1002/9781118504956.ch11
  13. 13. Malgoire, J. Y., Bertout, S., Renaud, F., Bastide, J. M., Mallié, M. (2005). Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism, Journal of Clinical Microbiology, 43(3), 1133-1137. http://dx.doi.org/10.1128/JCM.43.3.1133-1137.200510.1128/JCM.43.3.1133-1137.2005
  14. 14. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., Shafaghi, A. (2003). Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World Journal of Gastroenterology, 9(8), 1832-1833. http://dx.doi.org/10.3748/wjg.v9.i8.183210.3748/wjg.v9.i8.1832
  15. 15. McFarland, L. V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology, 101(4), 812-822. http://dx.doi.org/10.1111/j.1572-0241.2006.00465.x10.1111/j.1572-0241.2006.00465.x
  16. 16. McFarland, L. V. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterol, 16(18), 2202-2222. http://dx.doi.org/10.3748/wjg.v16.i18.220210.3748/wjg.v16.i18.2202
  17. 17. McGroarty, J. (1993). Probiotics use of lactobacilli in the human female urogenital tract. FEMS Immunology and Medical Microbiology, 6(4), 251-264. http://dx.doi.org/10.1111/j.1574-695X.1993.tb00337.x10.1111/j.1574-695X.1993.tb00337.x
  18. 18. Perdigon, G., Alvarez, S., Rachid, M., Agüero, G., Gobbato, N. (1995). Immune system stimulation by probiotics. Journal of Dairy Science, 78 (7), 1597-1606. http://dx.doi.org/10.3168/jds.S0022-0302(95)76784-410.3168/jds.S0022-0302(95)76784-4
  19. 19. Prabhu, A. A., Mandal, B., Dasu, V. V. (2017). Medium optimization for high yield production of extracellular human interferon-γ from Pichia pastoris: A statistical optimization and neural network-based approach. Korean Journal of Chemical Engineering, 34(4), 1109–1121. http://dx.doi.org/10.1007/s11814-016-0358-110.1007/s11814-016-0358-1
  20. 20. Szajewska, H., Mrukowicz, J. (2005). Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Alimentary Pharmacology and Therapeutics, 22(5), 365-372. http://dx.doi.org/10.1111/j.1365-2036.2005.02624.x10.1111/j.1365-2036.2005.02624.x16128673
  21. 21. Szajewska, H., Skorka, A., Dylag, M. (2007). Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Alimentary Pharmacology and Therapeutics, 25(3), 257-264. http://dx.doi.org/10.1111/j.1365-2036.2006.03202.x10.1111/j.1365-2036.2006.03202.x17269987
  22. 22. Vanhee, L. M. E., Goemé F., Nelis, H. J., Coenye, T. (2010). Quality control of fifteen probiotic products containing Saccharomyces boulardii. Journal of Applied Microbiology, 109(5).10.1111/j.1365-2672.2010.04805.x20636342
DOI: https://doi.org/10.2478/aucft-2019-0013 | Journal eISSN: 2344-150X | Journal ISSN: 2344-1496
Language: English
Page range: 101 - 108
Submitted on: Oct 29, 2019
|
Accepted on: Dec 6, 2019
|
Published on: Dec 30, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2019 Xin Yang, Guowei Shu, Zhangteng Lei, Guanli Du, Zemin Liu, Jili Cao, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.